Public contracts: Medical equipment and pharmaceuticals
CPV 33: Medical equipments, pharmaceuticals and personal care products. Public buyers in Germany, every notice in the EU tender journal TED since 2020. Data as of 30 Oct 2026.
In 2025, German public buyers published 2,331 tenders and 5,892 awards in this sector. 31% of the awards that state the number of bids received a single bid.
Contracts per year
| Year | Tenders | Awards | with stated value | Sum of stated values | Median | single bid | price only |
|---|---|---|---|---|---|---|---|
| 2020 | 1,571 | 6,407 | 391 | EUR 1.40bn | EUR 470k | 49% | 89% |
| 2021 | 2,458 | 8,464 | 336 | EUR 361.0m | EUR 224k | 38% | 92% |
| 2022 | 2,321 | 8,863 | 376 | EUR 210.2m | EUR 221k | 39% | 90% |
| 2023 | 2,432 | 10,123 | 274 | EUR 166.6m | EUR 276k | 37% | 73% |
| 2024 | 2,193 | 5,105 | 121 | EUR 102.3m | EUR 285k | 32% | 53% |
| 2025 | 2,331 | 5,892 | 499 | EUR 226.4m | EUR 213k | 31% | 55% |
| 2026 (to 30 Oct) | 2,192 | 5,141 | 736 | EUR 613.6m | EUR 356k | 28% | 78% |
Tenders: contract notices. Awards: awarded lots from contract award notices. Stated values exclude framework agreements whose notice gives only the maximum value. Many awards state no value, so the sum is not the market volume. How the figures are made
How contracts are awarded
- Awards with a single bid
- 33%
- of 21,735 awards that state the number of bids
- Awarded on price alone
- 66%
- of 25,402 awards that state the criteria
- Price and quality
- 23%
- at least one quality criterion besides price
- Cost alone
- 11%
- such as life-cycle cost instead of the bid price
Period 1 Jan 2023 to 30 Oct 2026. Notices rarely give the weighting of the criteria in figures, so the count shows which kind of criteria the buyer states.
Largest buyers
Regular contractors
| # | Name | Awards |
|---|---|---|
| 1 | HEXAL AG | 872 |
| 2 | ratiopharm GmbH | 706 |
| 3 | PUREN Pharma GmbH & Co. KG | 625 |
| 4 | Zentiva Pharma GmbH | 489 |
| 5 | Viatris Healthcare GmbH | 382 |
| 6 | Aristo Pharma GmbH | 343 |
| 7 | Fresenius Kabi Deutschland GmbH | 334 |
| 8 | B. Braun Deutschland GmbH & Co. KG | 318 |
| 9 | STADAPHARM GmbH | 309 |
| 10 | Pfizer Pharma GmbH | 305 |
Period 1 Jan 2023 to 30 Oct 2026. Different spellings of the same body are merged. Only companies with a legal form and public bodies are named, never individuals.
Contracts whose successor is being prepared now
4,264 contracts for a recurring need end between 30 Apr 2027 and 30 Apr 2028 according to their notice, 2,842 of them framework agreements. The list names buyer, subject and current contractor, and can be filtered by federal state, buyer and month.
A report and support for your bid
For your company, we compile a report on the expiring contracts that match what you sell: term and extension options, contract value as stated in the notice (for framework agreements the maximum value), previous contractors and award criteria. A person checks every report.
When a contract is tendered again, we support your bid: bid strategy, requirements matrix, writing the bid and submitting it on time. We work in German and English.